Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Cyclerion Therapeutics, Inc. (CYCN) had Return on Investments of -10.23% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.88M |
|
$-0.98M |
|
-- |
|
$0.88M |
|
$1.88M |
|
$-1.01M |
|
$0.03M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
$-1.01M |
|
$-1.01M |
|
3.23M |
|
3.23M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$5.07M |
|
-- |
|
$5.35M |
|
$10.41M |
|
$0.88M |
|
-- |
|
-- |
|
$0.88M |
|
$9.54M |
|
$9.54M |
|
$9.54M |
|
3.69M |
|
| Cash Flow Statement Financials | |
$-1.74M |
|
$0.00M |
|
$3.07M |
|
$3.23M |
|
$4.57M |
|
$1.34M |
|
$0.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-114.97% |
|
-114.97% |
|
-- |
|
-111.54% |
|
-111.54% |
|
$-1.74M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
8.75 |
|
10.29 |
|
-10.23% |
|
-10.23% |
|
-9.37% |
|
|
Return on Investments |
-10.23% |
$2.58 |
|
$-0.54 |
|
$-0.54 |
|